Ayugen Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-10-2024
- Paid Up Capital ₹ 0.93 M
as on 18-10-2024
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.61 Cr
as on 18-10-2024
- Satisfied Charges ₹ 1.24 Cr
as on 18-10-2024
- Revenue -3.14%
(FY 2023)
- Profit -4.23%
(FY 2023)
- Ebitda 5.30%
(FY 2023)
- Net Worth 10.36%
(FY 2023)
- Total Assets 8.89%
(FY 2023)
About Ayugen Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.93 M.
The company currently has active open charges totaling ₹4.61 Cr. The company has closed loans amounting to ₹1.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
Megha Maddiwar and Kishor Yembarwar serve as directors at the Company.
- CIN/LLPIN
U24232PN2007PTC131172
- Company No.
131172
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ayugen Pharma Private Limited offer?
Ayugen Pharma Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Wet Wipes, Disinfectant Spray, Alcohol Surface Disinfectant, Hand Sanitizer & Disinfectant, Alcohol Based Hand Sanitizer, Hand Wash, Antibacterial Hand Wash, Disinfectant Chemicals, Broad Spectrum Disinfectant Chemical.
Who are the key members and board of directors at Ayugen Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kishor Yembarwar  | Managing Director | 27-Dec-2007 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Megha Maddiwar | Director | 27-Dec-2007 | Current |
Financial Performance of Ayugen Pharma.
Ayugen Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.14% decrease. The company also saw a slight decrease in profitability, with a 4.23% decrease in profit. The company's net worth Soared by an impressive increase of 10.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ayugen Pharma?
In 2023, Ayugen Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Oct 2023 | ₹3.00 M | Open |
Others Creation Date: 28 Oct 2020 | ₹6.14 M | Open |
Others Creation Date: 12 Aug 2010 | ₹3.70 Cr | Open |
How Many Employees Work at Ayugen Pharma?
Ayugen Pharma has a workforce of 46 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ayugen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ayugen Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
